CURE® Speaking Out

CURE spoke with the LUNGevity Foundation about lung cancer and its treatments, as well as aspects to cancer outside of day-to-day care.

CURE spoke with Dr. Ogori Kalu, on behalf of the Triple-Negative Breast Cancer Foundation, about the psychosocial effects from a diagnosis, as well as treatment and its side effects.

On behalf of the National Pancreas Foundation, CURE spoke with Dr. Michael Goggin, from Johns Hopkins Medicine, and Tom Birsic, an executive board member since the organization’s inception, about living with pancreatic cancer.

On behalf of the Cutaneous Lymphoma Foundation, CURE spoke with Drs. Steven M. Horwitz and Lauren Pinter-Brown about the basics of cutaneous T-cell lymphoma, as well as current treatment options and those being evaluated for the rare disease.

CURE spoke with representatives of the National Pancreas Foundation on treatment options and outcomes for pancreatic cancer.

On behalf of the American Lung Association, CURE spoke with two health care professionals about lung cancer screening, disparities in care and why clinical trials are important to consider.

On behalf of METAvivor, CURE spoke with Jamil Rivers and Kate Watson about metastatic breast cancer – from its treatment to how it affects individuals and their families.

CURE spoke with representatives of the National Pancreas Foundation on the basics of pancreatic cancer - from early screening to genomic and non-genomic risk factors.

CURE spoke with two physicians, on behalf of the Hairy Cell Leukemia Foundation, about the basics of the disease, as well as its diagnosis and treatment, and also about how patients can learn more about clinical trials.

On behalf of ZERO - The End of Prostate Cancer, CURE spoke with Dr. Charles Ryan about prostate cancer – including the basics, genetics of the disease, developments in advanced prostate cancer and racial disparities.

On behalf of the Multiple Myeloma Research Foundation, CURE spoke with five specialists to offer various resources for patients with multiple myeloma.

CURE speaks with Dr. Susan O'Brien, on behalf of the Leukemia and Lymphoma Society.